SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ajanta Pharma informs about updates

20 Mar 2025 Evaluate

Ajanta Pharma has informed that the Company is expanding its manufacturing capabilities by adding a state-of-the-art liquid formulation facility at its Pithampur site. This enhancement is aimed at meeting the growing global demand for the Company's liquid formulations. The details, as required pursuant to Regulation 30 (4) (c) of the Listing Regulations, are enclosed. The above information is also being uploaded on the website of the Company at https://www.ajantapharma.com/.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2783.20 -6.95 (-0.25%)
20-Apr-2026 15:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.95
Dr. Reddys Lab 1233.20
Cipla 1231.45
Zydus Lifesciences 937.70
Lupin 2329.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×